Smith & Nephew plc (SNN)

NYSE: SNN · Real-Time Price · USD

36.90

+0.22 (0.60%)

Feb 27, 2026, 4:00 PM EST - Market closed

0.60% (1D)

Market Cap	15.69B
Revenue (ttm)	5.94B
Net Income (ttm)	491.00M
Shares Out	874.63M
EPS (ttm)	0.56
PE Ratio	31.95
Forward PE	16.77
Dividend	$0.73 (1.98%)
Ex-Dividend Date	Oct 3, 2025

Volume	1,321,371
Open	36.55
Previous Close	36.68
Day's Range	36.49 - 37.09
52-Week Range	23.91 - 38.79
Beta	0.65
Analysts	Hold
Price Target	35.75 (-11.03%)
Earnings Date	Mar 2, 2026

About SNN

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction proced... [Read more]

Industry Medical Devices

Sector Healthcare

IPO Date Nov 16, 1999

Employees 18,060

Stock Exchange NYSE

Ticker Symbol SNN

Website https://www.smith-nephew.com

Full Company Profile

Financial Performance

In 2024, Smith & Nephew's revenue was $5.81 billion, an increase of 4.70% compared to the previous year's $5.55 billion. Earnings were $412.00 million, an increase of 56.65%.

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for SNN stock is "Hold." The 12-month stock price target is $35.75, which is a decrease of -11.03% from the latest price.

Price Target

$35.75

(-11.03% downside)

Analyst Consensus: Hold

Stock Forecasts

News

There is no news available yet.